These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 6130172)

  • 1. [Prevention of myocardial infarction by chemotherapy].
    Toshima H; Adachi K
    Nihon Rinsho; 1982; 40(11):2465-70. PubMed ID: 6130172
    [No Abstract]   [Full Text] [Related]  

  • 2. [Aftercare of heart infarct patients to reduce the risk of a subsequent infarction].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1983 Apr; 127(16):673-9. PubMed ID: 6134240
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiac death prevention in post-myocardial infarction patients: a review.
    Boissel JP; Leizorovicz A; Faucomprez C
    Acta Cardiol Suppl; 1980; (25):147-79. PubMed ID: 6103625
    [No Abstract]   [Full Text] [Related]  

  • 4. [Secondary prevention following myocardial infarct. Platelet aggregation inhibitors, beta receptor blockers, antiarrhythmics].
    Schröder R
    Dtsch Med Wochenschr; 1981 Apr; 106(17):546-53. PubMed ID: 6111439
    [No Abstract]   [Full Text] [Related]  

  • 5. Secondary prevention after myocardial infarction: a review of long-term trials.
    May GS; Eberlein KA; Furberg CD; Passamani ER; DeMets DL
    Prog Cardiovasc Dis; 1982; 24(4):331-52. PubMed ID: 6119737
    [No Abstract]   [Full Text] [Related]  

  • 6. [Infarction prophylaxis--prevention of the sudden heart death? An alternative].
    Gross F
    MMW Munch Med Wochenschr; 1982 May; 124(18):435-6. PubMed ID: 6124885
    [No Abstract]   [Full Text] [Related]  

  • 7. Secondary prevention of myocardial infarction with drugs.
    Klimt CR; Forman SA
    Isr J Med Sci; 1983 May; 19(5):460-70. PubMed ID: 6134697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial infarction.
    Prentice CR
    Clin Haematol; 1981 Jun; 10(2):521-41. PubMed ID: 7032787
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiplatelet agents in prevention of myocardial infarction.
    Kshirsagar NA
    Indian Heart J; 1983; 35(1):60-6. PubMed ID: 6303947
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of myocardial infarct with anticoagulants, thrombolytics, inhibitors of platelet aggregation and beta receptor blockaders].
    Thiele R
    Z Arztl Fortbild (Jena); 1984; 78(5):167-71. PubMed ID: 6202068
    [No Abstract]   [Full Text] [Related]  

  • 11. [Correction of thrombophilia].
    Caruzzo C; Marcolongo M; Arpino E; Di Summa M
    Minerva Cardioangiol; 1981; 29(1-2):13-8. PubMed ID: 6112717
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic interventions in acute myocardial infarction. Survey of the ACCP Section on Clinical Cardiology.
    Dalen JE; Goldberg RJ; Gore JM; Struckus J
    Chest; 1984 Aug; 86(2):257-62. PubMed ID: 6146500
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drug therapy as secondary prevention following myocardial infarction].
    Cottier C
    Praxis (Bern 1994); 1996 Apr; 85(17):545-7. PubMed ID: 8668892
    [No Abstract]   [Full Text] [Related]  

  • 14. [Secondary prevention following a myocardial infarct].
    Enjalbert M; Théroux P; Bourassa MG
    Union Med Can; 1983 Mar; 112(3):219-20, 225-8, 234. PubMed ID: 6134369
    [No Abstract]   [Full Text] [Related]  

  • 15. Secondary prevention of myocardial infarction--the present state of the ART.
    Mitchell JR
    Br Med J; 1980 May; 280(6223):1128-30. PubMed ID: 7000236
    [No Abstract]   [Full Text] [Related]  

  • 16. Secondary prevention of coronary events after myocardial infarction. Beta-blockers and/or anti-platelets: to whom, when and for how long. A review.
    Bélanger GL; Lavallée JP; Lenis J; Ouellet CA
    Can J Cardiol; 1985 Mar; 1(2):97-105. PubMed ID: 2864991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelets and prostaglandins in sudden death: therapeutic implications.
    Gelman JS; Mehta J
    Cardiovasc Clin; 1985; 15(3):65-80. PubMed ID: 2870807
    [No Abstract]   [Full Text] [Related]  

  • 18. Anticoagulants and platelet-active agents in the secondary prevention of coronary artery disease.
    Van Aken WG
    Adv Cardiol; 1982; 31():98-101. PubMed ID: 6758512
    [No Abstract]   [Full Text] [Related]  

  • 19. E.P.S.I.M., the French oral anticoagulant--aspirin trial in post-myocardial infarction patients: design, organization and quality control procedures.
    Boissel JP; Leizorovicz A; Schbath J; Destors JM; Gillet J
    Scand J Haematol Suppl; 1981; 38():47-72. PubMed ID: 7038857
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical application and evaluation of anti-platelet agents].
    Yasunaga K
    Nihon Rinsho; 1978 Dec; 36(12):3884-94. PubMed ID: 372628
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.